Claybrook Capital’s CVS Health CVS Stock Holding History

Claybrook Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,200	Closed	-$1M	–	94
2020 Q3	$1M	Hold	17,200	–	–	0.75%	40
2020 Q2	$1.12M	Sell	17,200 -500	-3%	-$31.5K	0.96%	36
2020 Q1	$1.05M	Buy	17,700 +100	+0.6%	+$6.68K	0.95%	34
2019 Q4	$1.24M	Buy	17,600 +100	+0.6%	+$7.02K	0.58%	58
2019 Q3	$1.1M	Hold	17,500	–	–	0.57%	57
2019 Q2	$954K	Buy	17,500 +300	+2%	+$16.2K	0.5%	59
2019 Q1	$928K	Buy	17,200 +16,815	+4,368%	+$1.04M	0.49%	59
2018 Q4	$25K	Sell	385 -14,615	-97%	-$1.09M	0.01%	323
2018 Q3	$1.18M	Hold	15,000	–	–	0.69%	47
2018 Q2	$965K	Hold	15,000	–	–	0.61%	46
2018 Q1	$933K	Buy	15,000 +300	+2%	+$21.5K	0.61%	45
2017 Q4	$1.07M	Buy	+14,700	New	+$1.07M	0.76%	37

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Claybrook Capital's CVS Position: Q4 2020 in Review

Claybrook Capital sold out of CVS Health (CVS) in Q4 2020, closing a stake of 17,200 shares — an estimated $1M sold.

Claybrook Capital first reported a position in CVS in Q4 2017 and held it in 12 quarters. The position peaked at $1.24M in Q4 2019. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

Claybrook Capital reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
Claybrook Capital sold 17,200 CVS Health shares in Q4 2020, an estimated $1M.
Claybrook Capital first reported a position in CVS Health in Q4 2017 and held it in 12 quarters.
Claybrook Capital's CVS Health position peaked at $1.24M in Q4 2019.
1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Claybrook Capital's 13F filing for Q4 2020, filed 2 Feb 2021.